Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025- Change Your Skincare: 10 Inventive Magnificence Gadgets
- The most effective method to Pick a Campervan That Offers Something else for Less
- Must-See Public Parks from Around the Globe
- Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- The Manual for Well known rough terrain Vehicles
- Interstellar comet 3I/ATLAS will fly by Earth Friday. Here are the latest images
- Tech for Wellbeing: Applications and Devices for a Better You
- The most effective method to Help a Friend or family member Determined to have Cellular breakdown in the lungs
